Matthew Perry’s Death Darkens Ketamine’s Startup Glow
By Rolfe Winkler and Brianna AbbottDec. 16, 2023 9:00 pm ETMatthew Perry’s death from the effects of ketamine brought new...
Mental Disorders
First Pill for Postpartum Depression Is Approved by FDA
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a...
FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients
HealthMedicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy Source link
An Uneasy Use for Apple’s AirTags: Tracking a Loved One With Dementia
Michelle Hirschboeck was looking for a way to keep track of her husband, Paul, who has dementia. She settled on...
Alzheimer’s Drug Slows Disease Progression in Trial
The pharmaceutical companies said their drug lecanemab reduced cognitive and functional decline by 27%, compared with a placebo, over 18...
Millions of Americans Are Turning to Therapy, and Investors See an Opportunity
Psychiatrists and psychologists once ran their own practices. Now the local therapist office could be controlled by a buyout king.Venture...
From GM to Powerade, Brands Pitch Mental Health
To woo consumers, hotel chains typically offer free room upgrades and complimentary breakfast. Kimpton Hotels is trying a new incentive:...
Startups Make It Easier to Get ADHD Drugs. That Made Some Workers Anxious.
Cris Wibby joined online mental-health company Cerebral Inc. as a nurse practitioner last spring, looking for the flexibility to work...
FDA Rejects Short Sellers’ Request to Halt Trials of Alzheimer’s Drug
The Food and Drug Administration has denied a petition by short sellers to halt clinical trials of an experimental Alzheimer’s...
Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial Patients
Medicare officials said they would cover Biogen Inc.’s BIIB 2.64% controversial Alzheimer’s disease drug Aduhelm on the condition that patients...
Cleveland Clinic, Mount Sinai and Providence Won’t Give Biogen’s New Alzheimer’s Drug
Three large hospitals are declining to administer Biogen Inc.’s BIIB -6.79% new Alzheimer’s treatment, Aduhelm, the latest rupture to emerge...
FDA Approved Biogen Alzheimer’s Drug Despite Some Staff Concerns
The U.S. Food and Drug Administration approved the first new Alzheimer’s drug in decades over the objection of agency statisticians...
Pill-Dispensing Tech Makes the Medicine Go Down…With Human Help, That Is
When Stephanie Luehrs’s father began losing track of what day it was, she knew his pre-filled pill packs were no...
Lilly Alzheimer’s Drug Shows Modest Benefit in Clinical Trial
An Eli Lilly LLY 1.40% & Co. experimental drug modestly slowed the cognitive and functional decline of early-stage Alzheimer’s patients...
WSJ News Exclusive | Amazon Won’t Sell Books Framing LGBTQ+ Identities as Mental Illnesses
Amazon. AMZN 1.83% com Inc. said it recently removed a three-year-old book about transgender issues from its platforms because it...
